793 related articles for article (PubMed ID: 3524815)
1. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity characteristics of reverse diol-epoxides of chrysene.
Glatt H; Wameling C; Elsberg S; Thomas H; Marquardt H; Hewer A; Phillips DH; Oesch F; Seidel A
Carcinogenesis; 1993 Jan; 14(1):11-9. PubMed ID: 8425257
[TBL] [Abstract][Full Text] [Related]
3. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
Glatt H; Piée A; Pauly K; Steinbrecher T; Schrode R; Oesch F; Seidel A
Cancer Res; 1991 Mar; 51(6):1659-67. PubMed ID: 1900215
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
5. Mutagenicity of the enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
Wood AW; Chang RL; Levin W; Yagi H; Thakker DR; van Bladeren PJ; Jerina DM; Conney AH
Cancer Res; 1983 Dec; 43(12 Pt 1):5821-5. PubMed ID: 6357432
[TBL] [Abstract][Full Text] [Related]
6. Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.
Wood AW; Chang RL; Levin W; Kumar S; Shirai N; Jerina DM; Lehr RE; Conney AH
Cancer Res; 1986 Jun; 46(6):2760-6. PubMed ID: 3516386
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity of the optical isomers of the diastereomeric bay-region chrysene 1,3-diol-3,4-epoxides in bacterial and mammalian cells.
Wood AW; Chang RL; Levin W; Yagi H; Tada M; Vyas KP; Jerina DM; Conney AH
Cancer Res; 1982 Aug; 42(8):2972-6. PubMed ID: 7046912
[TBL] [Abstract][Full Text] [Related]
9. Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo(f)quinoline and benzo(h)quinoline.
Kumar S; Sikka HC; Dubey SK; Czech A; Geddie N; Wang CX; LaVoie EJ
Cancer Res; 1989 Jan; 49(1):20-4. PubMed ID: 2908847
[TBL] [Abstract][Full Text] [Related]
10. Mutagenic potential of DNA adducts formed by diol-epoxides, triol-epoxides and the K-region epoxide of chrysene in mammalian cells.
Phillips DH; Glatt HR; Seidel A; Bochnitschek W; Oesch F; Grover PL
Carcinogenesis; 1986 Oct; 7(10):1739-43. PubMed ID: 3757175
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic activity of the 4,5- and 9,10-dihydrodiols of benzo[j]fluoranthene and their syn- and anti-dihydrodiol epoxides in Salmonella typhimurium.
Marshall MV; He ZM; Weyand EH; Rice JE; LaVoie EJ
Environ Mol Mutagen; 1993; 22(1):34-45. PubMed ID: 8339723
[TBL] [Abstract][Full Text] [Related]
12. Mutagenicity of the enantiomers of the diastereomeric bay-region benzo(c)phenanthrene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
Wood AW; Chang RL; Levin W; Thakker DR; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1984 Jun; 44(6):2320-4. PubMed ID: 6372992
[TBL] [Abstract][Full Text] [Related]
13. Reactivity with DNA bases and mutagenicity toward Salmonella typhimurium of methylchrysene diol epoxide enantiomers.
Melikian AA; Amin S; Huie K; Hecht SS; Harvey RG
Cancer Res; 1988 Apr; 48(7):1781-7. PubMed ID: 3258179
[TBL] [Abstract][Full Text] [Related]
14. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
Wood AW; Wislocki PG; Chang RL; Levin W; Lu AY; Yagi J; Hernandez O; Herina DM; Conney AH
Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
[TBL] [Abstract][Full Text] [Related]
16. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
[TBL] [Abstract][Full Text] [Related]
17. Mutagenicity of dihydrodiols and diol epoxides of dibenz[a, h]acridine in bacterial and mammalian cells.
Wood AW; Chang RL; Katz M; Conney AH; Jerina DM; Sikka HC; Levin W; Kumar S
Cancer Res; 1989 Dec; 49(24 Pt 1):6981-4. PubMed ID: 2684405
[TBL] [Abstract][Full Text] [Related]
18. Multiple activation pathways of benzene leading to products with varying genotoxic characteristics.
Glatt H; Padykula R; Berchtold GA; Ludewig G; Platt KL; Klein J; Oesch F
Environ Health Perspect; 1989 Jul; 82():81-9. PubMed ID: 2676505
[TBL] [Abstract][Full Text] [Related]
19. The formation of 9-hydroxychrysene-1,2-diol as an intermediate in the metabolic activation of chrysene.
Hodgson RM; Seidel A; Bochnitschek W; Glatt HR; Oesch F; Grover PL
Carcinogenesis; 1985 Jan; 6(1):135-9. PubMed ID: 3967334
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of benzo[c]chrysene and comparative mammary gland tumorigenesis of benzo[c]chrysene bay and fjord region diol epoxides in female CD rats.
Amin S; Lin JM; Krzeminski J; Boyiri T; Desai D; El-Bayoumy K
Chem Res Toxicol; 2003 Feb; 16(2):227-31. PubMed ID: 12588194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
